U.S. Basic Materials Stock News

MasTec (NYSE:MTZ) held an in-depth Investor Day, outlining multi-year targets for its business. Management detailed how the company is positioned to serve power delivery, clean energy, and data center infrastructure demand. The event included a raised multi-year outlook and granular discussion of grid modernization and data center related projects. For investors watching NYSE:MTZ, the Investor Day comes after a significant rise in the stock, with shares up 86.2% year to date and 169.4% over...

In the last week, the United States market has stayed flat, yet it is up 25% over the past year with earnings anticipated to grow by 17% annually in the coming years. In this context of overall growth and stability, identifying stocks that may be trading at an estimated discount can offer investors potential opportunities for value investing.

In the last week, the United States market has stayed flat, yet it has seen a remarkable 25% increase over the past year with earnings forecasted to grow by 17% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its potential for continued success.

Over the last 7 days, the market has remained flat, but it is up 25% over the past year with earnings forecast to grow by 17% annually. In such a climate, identifying stocks with strong financial foundations can be key to finding value and growth opportunities. Penny stocks, although an older term, remain relevant as they often represent smaller or newer companies that may offer significant potential when backed by solid fundamentals.

The United States market has seen a flat performance over the last week but has experienced a notable 25% increase over the past year, with earnings projected to grow by 17% annually. In this dynamic environment, identifying undiscovered gems often involves finding stocks that offer unique growth potential and align with these promising earnings forecasts.

In the last week, the United States market has stayed flat, yet it is up 25% over the past year with earnings forecast to grow by 17% annually. In such a dynamic environment, identifying leading dividend stocks that offer both stability and attractive yields can be a strategic approach for investors seeking income and potential growth.

Recent interest in NVE (NVEC) has picked up after Semitech was appointed an authorized distributor for the company’s isolation products. The move is aimed at widening access to its digital isolation solutions in the U.S. See our latest analysis for NVE. NVE’s recent distributor agreement with Semitech and the latest full year results, which showed revenue of US$26.33 million and net income of US$15.2 million, have coincided with strong momentum. This includes a 30 day share price return of...

NextDecade (NEXT) has filed a shelf registration to offer up to 19,730,742 shares of common stock, totaling about US$167.7 million. This move could influence dilution expectations and future funding flexibility for investors. See our latest analysis for NextDecade. The shelf registration comes after a wider period of strong share price momentum, with a 7 day share price return of 14.17% and a 90 day share price return of 67.45%. At the same time, the 1 year total shareholder return of 4.15%...

Accenture Federal Services and OpenAI have entered into a new partnership to support AI adoption across U.S. federal agencies. Under the collaboration, Accenture Federal Services will act as an implementation partner to help agencies deploy, scale, and govern advanced AI tools. The focus includes generative AI use cases in mission-driven environments, while addressing compliance, security, and modernization requirements. For investors tracking Accenture (NYSE:ACN), this partnership adds a...

What Halozyme’s Q1 earnings mean for stock watchers Halozyme Therapeutics (HALO) just put out a busy Q1 2026 update, combining strong year-over-year growth in revenue and earnings with reaffirmed full year guidance and a fresh US$1b share repurchase program. The quarter was also active on the partnership side, with a new global collaboration around the ENHANZE drug delivery platform and oncology targets, giving investors more concrete data points to weigh against recent share price moves. See...

Omeros Corporation reported past first-quarter 2026 results showing sales of US$9.89 million and a shift from a net loss to net income of US$56.06 million, with both basic and diluted earnings per share turning positive versus the prior year. Beyond the headline profit swing, the quarter reflects earnings power influenced by noncash items and comes alongside ongoing regulatory and clinical momentum for YARTEMLEA and the broader complement pipeline. We’ll now examine how this sharp earnings...

Venture Global (VG) opened Q1 2026 with revenue of US$4.6 billion and basic EPS of US$0.22, setting the tone for how investors will read the latest move in both the top and bottom line. Over the past year, the company has seen quarterly revenue move from US$2,894 million in Q1 2025 to US$4,599 million in Q1 2026, while basic EPS shifted from US$0.17 to US$0.22 across the same periods, giving a clear sense of how sales and per share profitability are tracking into the new fiscal year. With...

In early May 2026, Assurant reported first-quarter 2026 results showing revenue of US$3,420.1 million and net income of US$274.1 million, alongside completing two share repurchase tranches totaling 556,137 shares for US$124.78 million under its ongoing buyback programs. The sharp increase in quarterly earnings per share from continuing operations, coupled with the continued execution of sizable buybacks, highlights how Assurant is combining earnings strength with capital returns to...

Kymera Therapeutics recently reported first-quarter 2026 results, while also announcing preclinical data showing that KT-579, its investigational oral IRF5 degrader, achieved disease-modifying activity in an inflammatory bowel disease model and matched or exceeded benchmark therapies in several measures of inflammation and tissue health. The data suggest KT-579 could offer biologics-like immune pathway control in a pill, potentially broadening treatment options across multiple complex...

Calumet (CLMT) opened the quarter with an earnings update that will likely catch investors’ attention, as sales reached US$1,029.7 million while the company reported a wider net loss of US$317 million. See our latest analysis for Calumet. The latest earnings update comes after a strong run in Calumet’s stock, with the share price at US$31.43 and a year to date share price return of 60.77%, while the 1 year total shareholder return of 126.60% suggests momentum has been strong despite recent...

J&J Snack Foods (JJSF) is back in focus after reporting second quarter and six month results that showed lower sales and net income compared with a year earlier, raising fresh questions about operating momentum. See our latest analysis for J&J Snack Foods. The latest earnings and completed share buyback have played out against a weaker backdrop, with the share price at $71.57 and a year to date share price return down 20.93%, while the 1 year total shareholder return has fallen 35.43%,...

Earlier this month, plaintiffs in a nationwide false advertising class action asked a U.S. court to preliminarily approve a US$250.00 billion settlement with Apple over marketing of “Apple Intelligence” on select iPhone 15 and iPhone 16 models, while Apple also reported second‑quarter revenue of US$111.18 billion and net income of US$29.58 billion, raised its dividend to US$0.27 per share, and authorized up to US$100.00 billion in share repurchases. The combination of a large proposed...

Wondering whether A. O. Smith at around US$56.98 is starting to look like value, or if the recent weakness is a warning sign for your portfolio? The stock has pulled back recently, with the share price down 6.7% over the past week, 15.2% over the past month, 16.6% year to date, and 14.9% over the past year. This may signal shifting views on its growth potential or risk profile. These moves have come as investors reassess established industrial stocks and refocus on pricing, capital...

Bit Digital (BTBT) is back in focus after appointing Daniel Kennedy as Head of Investor Relations and confirming its Q1 2026 earnings release and management call, scheduled for May 14, 2026. See our latest analysis for Bit Digital. Those Q1 expectations and the investor relations reshuffle come after a 40.97% 1 month share price return. However, the 1 year total shareholder return is still down 5.14%, so recent momentum contrasts with weaker longer term results. If Bit Digital’s mix of...

Macerich (MAC) has just completed a follow on equity offering, raising about US$403.2 million by selling 19,200,000 common shares at US$21 each. This move is tied directly to its Annapolis Mall acquisition. See our latest analysis for Macerich. The follow on offering comes after a period of solid momentum, with the share price returning 23.36% over 90 days and 18.63% year to date. The 1 year total shareholder return sits at 46.11% and the 5 year total shareholder return at 88.75%, pointing to...

Wondering if Pegasystems at around US$32.72 is a bargain or a value trap? This article walks through the key numbers you need to size that up. The stock is down about 10% over the past week, 21.3% over the past month, 41.6% year to date and 33% over the past year. The 3-year return sits at 49.6%, and the 5-year return is down 43.9%. Recent headlines around Pegasystems have focused on its position within the software sector and shifting sentiment toward growth oriented platforms. This helps...

Investors considering Global-E Online at around US$27.54 may be wondering whether the stock is starting to look attractive or if the recent weakness is a warning sign. This article focuses on what the current price might imply about value. The stock has retreated recently, with returns down 11.8% over the last week, 9.8% over the last month, 27.3% year to date and 19.7% over the past year. Recent news around Global-E Online has centered on its role as a cross border e-commerce enablement...

For investors considering whether C.H. Robinson Worldwide at around US$163 per share is priced for further gains or already reflects its current story, this article explains what the current valuation signals may be indicating. The stock has pulled back, with returns declining 3.2% over the past week and 1.0% over the past month, while still showing a 69.7% return over 1 year, 74.3% over 3 years and 88.4% over 5 years. Recent headlines have focused on C.H. Robinson Worldwide's role in global...

Core Natural Resources, Inc. recently reported first-quarter 2026 results showing sales of US$1,084.28 million and net income of US$21.04 million, while also affirming a US$0.10 quarterly dividend and completing a share repurchase program covering 6.74% of its stock. Alongside the financial improvement, the company refreshed its leadership bench with two new directors and a new chief commercial officer, pointing to an increased focus on commercial execution and governance. With Core now back...